Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.

Citation metadata

Publisher: American Medical Association
Document Type: Report
Length: 33 words

Document controls

Main content

Abstract :

The efficacy of, and adverse events related to eptinezumab, when initiated during a migraine attack are examined. Results indicate that treatment with intravenous eptinezumab versus placebo shortened time to headache and symptom resolution.

Source Citation

Source Citation   

Gale Document Number: GALE|A671729488